- Home
- SNGX vs ARTW Comparison
SNGX vs ARTW Comparison
Compare SNGX & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- ARTW
- Stock Information
- Founded
- SNGX 1987
- ARTW 1956
- Country
- SNGX United States
- ARTW United States
- Employees
- SNGX N/A
- ARTW N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- ARTW Industrial Machinery/Components
- Sector
- SNGX Health Care
- ARTW Industrials
- Exchange
- SNGX Nasdaq
- ARTW Nasdaq
- Market Cap
- SNGX 6.1M
- ARTW 8.4M
- IPO Year
- SNGX 1987
- ARTW N/A
- Fundamental
- Price
- SNGX $2.27
- ARTW $1.65
- Analyst Decision
- SNGX
- ARTW
- Analyst Count
- SNGX 0
- ARTW 0
- Target Price
- SNGX N/A
- ARTW N/A
- AVG Volume (30 Days)
- SNGX 31.1K
- ARTW 25.4K
- Earning Date
- SNGX 03-21-2025
- ARTW 04-08-2025
- Dividend Yield
- SNGX N/A
- ARTW N/A
- EPS Growth
- SNGX N/A
- ARTW 17.02
- EPS
- SNGX N/A
- ARTW 0.06
- Revenue
- SNGX $364,183.00
- ARTW $24,499,371.00
- Revenue This Year
- SNGX N/A
- ARTW N/A
- Revenue Next Year
- SNGX $119.78
- ARTW N/A
- P/E Ratio
- SNGX N/A
- ARTW $27.45
- Revenue Growth
- SNGX N/A
- ARTW N/A
- 52 Week Low
- SNGX $1.83
- ARTW $1.33
- 52 Week High
- SNGX $14.88
- ARTW $4.15
- Technical
- Relative Strength Index (RSI)
- SNGX 47.11
- ARTW 46.91
- Support Level
- SNGX $2.21
- ARTW $1.55
- Resistance Level
- SNGX $2.40
- ARTW $1.69
- Average True Range (ATR)
- SNGX 0.12
- ARTW 0.07
- MACD
- SNGX 0.02
- ARTW 0.00
- Stochastic Oscillator
- SNGX 55.00
- ARTW 50.00
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.